Evo Fund lowers stake in SymBio Pharmaceuticals to 30.17%
Stake history
Summary
Evo Fund and joint holders filed a Change in 5%+ stake (change report) via EDINET on 2026-01-08 14:31 JST concerning SymBio Pharmaceuticals Limited. Reported holding ratio: 30.17%, previous report: 31.14%.